Chief Executive Officer & Co-Founder
As a researcher in Toronto, Acorn founder Dr. Drew Taylor saw an urgent need to prepare people for the future of medicine. He struggled to accept the scenario where we have to tell patients that “there is a stem cell therapy available for your condition, but unfortunately your cells are too old and damaged to be leveraged.” To solve this, he founded Acorn Biolabs in 2017.
Prior to founding Acorn, Drew spent several years as Chief Science Officer at Epic Capital Management working across the flourishing biotech start-up community. Prior to Epic, Drew was part of Mount Sinai Hospital’s BioEngineering of Skeletal Tissues Team.
Drew completed a bachelor’s degree in Biology and master’s degree in Molecular, Cellular & Developmental Biology at the University of Michigan and a PhD in Biomedical Engineering at the University of Toronto.
Drew also enjoyed a successful career in professional minor league baseball as a pitcher for both the Toronto Blue Jays and the Philadelphia Phillies. A career-ending injury spurred personal motivation to help unlock the future of regenerative medicine for everyone.